[1]
A. Duppenthaler, M. Gorgievski-Hrisoho, and C. Aebi, “Regional impact of prophylaxis with the monoclonal antibody palivizumab on ospitalizations from respiratory syncytial virus in infants”, Swiss Med Wkly, vol. 131, no. 1112, pp. 146–151, Mar. 2001.